Your browser doesn't support javascript.
loading
Cost effectiveness of an intervention to increase uptake of hepatitis C virus testing and treatment (HepCATT): cluster randomised controlled trial in primary care.
Roberts, Kirsty; Macleod, John; Metcalfe, Chris; Hollingworth, Will; Williams, Jack; Muir, Peter; Vickerman, Peter; Clement, Clare; Gordon, Fiona; Irving, Will; Waldron, Cherry-Ann; North, Paul; Moore, Philippa; Simmons, Ruth; Miners, Alec; Horwood, Jeremy; Hickman, Matthew.
Affiliation
  • Roberts K; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Macleod J; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Metcalfe C; NIHR Health Protection Research Unit (HPRU) in Evaluation of Interventions, University of Bristol, Bristol, UK.
  • Hollingworth W; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Williams J; Bristol Randomised Trials Collaboration (BRTC), Population Health Sciences, Bristol Medical School, Bristol, UK.
  • Muir P; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Vickerman P; Department of Health Service Research and Policy, London School of Hygiene & Tropical Medicine, London, UK.
  • Clement C; NIHR HPRU in Blood Borne Viruses and STI, University College London, London, UK.
  • Gordon F; Public Health Laboratory Bristol, National Infection Service, Public Health England, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
  • Irving W; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
  • Waldron CA; NIHR Health Protection Research Unit (HPRU) in Evaluation of Interventions, University of Bristol, Bristol, UK.
  • North P; NIHR Health Protection Research Unit (HPRU) in Evaluation of Interventions, University of Bristol, Bristol, UK.
  • Moore P; University Hospitals Bristol, Bristol Royal Infirmary, Bristol, UK.
  • Simmons R; NIHR Nottingham Digestive Diseases Biomedical Research Unit, University Hospital Nottingham, Nottingham, UK.
  • Miners A; Centre for Trials Research, Cardiff University, Cardiff, UK.
  • Horwood J; Public Health Laboratory Bristol, National Infection Service, Public Health England, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
  • Hickman M; Public Health Laboratory Bristol, National Infection Service, Public Health England, Pathology Sciences Building, Southmead Hospital, Bristol, UK.
BMJ ; 368: m322, 2020 02 26.
Article in En | MEDLINE | ID: mdl-32102782
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Outcome and Process Assessment, Health Care / Primary Health Care / Hepatitis C / Hepacivirus Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: BMJ Journal subject: MEDICINA Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Outcome and Process Assessment, Health Care / Primary Health Care / Hepatitis C / Hepacivirus Type of study: Clinical_trials / Health_economic_evaluation / Prognostic_studies Aspects: Patient_preference Limits: Humans Country/Region as subject: Europa Language: En Journal: BMJ Journal subject: MEDICINA Year: 2020 Document type: Article Affiliation country: Reino Unido Country of publication: Reino Unido